FAM227B
gene geneOn this page
Also known as FLJ32800
Summary
FAM227B (family with sequence similarity 227 member B, HGNC:26543) is a protein-coding gene on chromosome 15q21.2, encoding Protein FAM227B (Q96M60).
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 124 total
- MANE Select transcript:
NM_152647
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26543 |
| Approved symbol | FAM227B |
| Name | family with sequence similarity 227 member B |
| Location | 15q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32800 |
| Ensembl gene | ENSG00000166262 |
| Ensembl biotype | protein_coding |
| Entrez | 196951 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 8 protein_coding, 4 protein_coding_CDS_not_defined, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000299338, ENST00000557892, ENST00000558579, ENST00000558594, ENST00000558615, ENST00000558862, ENST00000559351, ENST00000559573, ENST00000559905, ENST00000560246, ENST00000560557, ENST00000561064, ENST00000561116, ENST00000561319, ENST00000968443, ENST00000968444
RefSeq mRNA: 2 — MANE Select: NM_152647
NM_001330293, NM_152647
CCDS: CCDS32237, CCDS81880
Canonical transcript exons
ENST00000299338 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001101519 | 49541680 | 49541806 |
| ENSE00001101530 | 49568245 | 49568346 |
| ENSE00001363504 | 49575011 | 49575109 |
| ENSE00001611442 | 49335419 | 49335496 |
| ENSE00001670437 | 49367448 | 49367608 |
| ENSE00002556968 | 49620700 | 49620818 |
| ENSE00002568101 | 49326970 | 49328675 |
| ENSE00002712073 | 49508211 | 49508348 |
| ENSE00003465675 | 49577629 | 49577664 |
| ENSE00003492889 | 49371302 | 49371399 |
| ENSE00003514590 | 49611215 | 49611268 |
| ENSE00003546155 | 49331780 | 49331849 |
| ENSE00003611331 | 49588016 | 49588083 |
| ENSE00003614479 | 49615121 | 49615243 |
| ENSE00003666805 | 49589776 | 49590007 |
| ENSE00003789912 | 49576741 | 49576845 |
Expression profiles
Bgee: expression breadth ubiquitous, 171 present calls, max score 89.18.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.6780 / max 91.0908, expressed in 1484 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 149819 | 2.8429 | 1223 |
| 149821 | 0.5775 | 314 |
| 149820 | 0.5724 | 333 |
| 149818 | 0.4499 | 226 |
| 149822 | 0.2353 | 107 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.18 | gold quality |
| buccal mucosa cell | CL:0002336 | 87.30 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.47 | gold quality |
| right uterine tube | UBERON:0001302 | 86.39 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.64 | gold quality |
| left testis | UBERON:0004533 | 85.31 | gold quality |
| right testis | UBERON:0004534 | 84.66 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 83.95 | gold quality |
| muscle of leg | UBERON:0001383 | 83.84 | gold quality |
| gastrocnemius | UBERON:0001388 | 83.78 | gold quality |
| testis | UBERON:0000473 | 83.38 | gold quality |
| islet of Langerhans | UBERON:0000006 | 83.08 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 82.74 | gold quality |
| left ovary | UBERON:0002119 | 82.48 | gold quality |
| right ovary | UBERON:0002118 | 81.90 | gold quality |
| tibial nerve | UBERON:0001323 | 81.28 | gold quality |
| adrenal tissue | UBERON:0018303 | 81.27 | gold quality |
| adenohypophysis | UBERON:0002196 | 81.24 | gold quality |
| right atrium auricular region | UBERON:0006631 | 81.04 | gold quality |
| right adrenal gland | UBERON:0001233 | 80.90 | gold quality |
| endocervix | UBERON:0000458 | 80.87 | gold quality |
| body of pancreas | UBERON:0001150 | 80.58 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 80.55 | gold quality |
| heart left ventricle | UBERON:0002084 | 80.28 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 80.14 | gold quality |
| left adrenal gland | UBERON:0001234 | 80.07 | gold quality |
| body of uterus | UBERON:0009853 | 80.05 | gold quality |
| cardiac atrium | UBERON:0002081 | 80.01 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 79.84 | gold quality |
| pancreas | UBERON:0001264 | 79.75 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.62 |
| E-MTAB-7303 | no | 172.85 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting FAM227B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-4802-3P | 99.72 | 70.13 | 1273 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-183-3P | 99.41 | 69.41 | 1598 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-4699-5P | 98.99 | 67.50 | 1210 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
| HSA-MIR-219A-2-3P | 98.62 | 68.78 | 797 |
| HSA-MIR-5585-3P | 98.25 | 67.41 | 941 |
| HSA-MIR-1255B-2-3P | 97.80 | 67.04 | 880 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
| HSA-MIR-675-3P | 95.77 | 69.27 | 675 |
| HSA-MIR-5009-5P | 94.82 | 63.89 | 775 |
| HSA-MIR-8058 | 94.76 | 63.41 | 632 |
| HSA-MIR-5186 | 94.63 | 66.76 | 627 |
| HSA-MIR-1269A | 92.75 | 64.61 | 542 |
| HSA-MIR-1269B | 92.75 | 64.73 | 538 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam227b | ENSMUSG00000027209 |
| rattus_norvegicus | Fam227b | ENSRNOG00000037124 |
Protein
Protein identifiers
Protein FAM227B — Q96M60 (reviewed: Q96M60)
All UniProt accessions (6): H0YK12, H0YLX5, H0YMU4, H0YMX9, H0YNN2, Q96M60
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM227 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96M60-1 | 1 | yes |
| Q96M60-2 | 2 |
RefSeq proteins (2): NP_001317222, NP_689860* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029417 | FAM227 | Family |
Pfam: PF14922
UniProt features (7 total): region of interest 2, splice variant 2, chain 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96M60-F1 | 71.40 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 92 (showing top):
AACWWCAANK_UNKNOWN, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN, PR_Q2, LEE_BMP2_TARGETS_DN, ALKBH3_TARGET_GENES, ARNT2_TARGET_GENES, BARX1_TARGET_GENES, CEBPZ_TARGET_GENES, CHAF1B_TARGET_GENES, DLX4_TARGET_GENES, FOXJ2_TARGET_GENES, GLI3_TARGET_GENES, GLI4_TARGET_GENES, HES2_TARGET_GENES, HMG20B_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
126 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM227B | LRRIQ3 | A6PVS8 | 620 |
| FAM227B | VXN | Q8TAG6 | 615 |
| FAM227B | RNF144A | P50876 | 560 |
| FAM227B | TMEM126B | Q8IUX1 | 515 |
| FAM227B | KIFC3 | Q9BVG8 | 515 |
| FAM227B | FPGT | O14772 | 507 |
| FAM227B | NOL4L | Q96MY1 | 499 |
| FAM227B | CYRIA | Q9H0Q0 | 496 |
| FAM227B | CFAP99 | D6REC4 | 480 |
| FAM227B | ROPN1L | Q96C74 | 463 |
| FAM227B | XPO4 | Q9C0E2 | 457 |
| FAM227B | RAPGEF5 | Q92565 | 449 |
| FAM227B | KIF2B | Q8N4N8 | 444 |
| FAM227B | CLSTN2 | Q9H4D0 | 421 |
| FAM227B | FOXI1 | Q12951 | 381 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM227B | NME2P1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (15): FAM227B (Affinity Capture-MS), CALML3 (Affinity Capture-MS), ACTA2 (Affinity Capture-MS), PPL (Affinity Capture-MS), EPPK1 (Affinity Capture-MS), VPS28 (Affinity Capture-MS), NME2P1 (Affinity Capture-MS), TYMP (Affinity Capture-MS), SERPINB4 (Affinity Capture-MS), SERPINB3 (Affinity Capture-MS), HIST2H2AC (Affinity Capture-MS), EVPL (Affinity Capture-MS), ACTB (Affinity Capture-MS), SERPINA3 (Affinity Capture-MS), SERPINB5 (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GVH7, A6PVS8, A8DZJ1, A9Q751, D3ZSP7, D4AEC2, Q08AD1, Q08CX2, Q14DL3, Q2T9P0, Q2TA00, Q32KQ1, Q3UZ57, Q3V0J4, Q4G0U5, Q4R7B1, Q4R7Z7, Q5S003, Q5SUV2, Q5T1B0, Q5ZLS8, Q63164, Q66HC0, Q69CM7, Q6AXP3, Q6AYL8, Q6IRN6, Q6NXP0, Q6Q759, Q80X60, Q86WZ0, Q8C1B1, Q8C4J0, Q8C636, Q8CDN1, Q8CDU5, Q8IWF9, Q8N7B9, Q8N7U6, Q8ND61
Diamond homologs: F5H4B4, Q4R7D5, Q6AXP3, Q96M60, Q9D518
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
124 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 96 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4575 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:49371298:AAACC:A | donor_loss | 1.0000 |
| 15:49371299:AACCT:A | donor_loss | 1.0000 |
| 15:49371301:C:CG | donor_loss | 1.0000 |
| 15:49371333:T:TA | donor_gain | 1.0000 |
| 15:49371397:TAC:T | acceptor_gain | 1.0000 |
| 15:49371399:CCTA:C | acceptor_loss | 1.0000 |
| 15:49371400:C:CC | acceptor_gain | 1.0000 |
| 15:49371400:CTAAA:C | acceptor_loss | 1.0000 |
| 15:49371406:C:CT | acceptor_gain | 1.0000 |
| 15:49483136:T:A | acceptor_gain | 1.0000 |
| 15:49483138:T:TA | acceptor_gain | 1.0000 |
| 15:49483147:GCA:G | acceptor_loss | 1.0000 |
| 15:49483148:CA:C | acceptor_loss | 1.0000 |
| 15:49483149:A:AG | acceptor_gain | 1.0000 |
| 15:49483150:G:GC | acceptor_gain | 1.0000 |
| 15:49483150:GA:G | acceptor_gain | 1.0000 |
| 15:49483150:GAT:G | acceptor_gain | 1.0000 |
| 15:49483150:GATA:G | acceptor_gain | 1.0000 |
| 15:49483150:GATAT:G | acceptor_gain | 1.0000 |
| 15:49483202:TGGA:T | donor_gain | 1.0000 |
| 15:49483234:G:GT | donor_gain | 1.0000 |
| 15:49483235:A:T | donor_gain | 1.0000 |
| 15:49483250:CAAAG:C | donor_loss | 1.0000 |
| 15:49483251:AAAGG:A | donor_loss | 1.0000 |
| 15:49483252:AAGGT:A | donor_loss | 1.0000 |
| 15:49483253:AGGT:A | donor_loss | 1.0000 |
| 15:49483256:T:G | donor_loss | 1.0000 |
| 15:49484305:AACAG:A | acceptor_loss | 1.0000 |
| 15:49484306:ACAGA:A | acceptor_loss | 1.0000 |
| 15:49484308:A:AG | acceptor_gain | 1.0000 |
AlphaMissense
3383 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:49367546:A:C | S391R | 0.992 |
| 15:49367546:A:T | S391R | 0.992 |
| 15:49367548:T:G | S391R | 0.992 |
| 15:49541689:A:G | W289R | 0.992 |
| 15:49541689:A:T | W289R | 0.992 |
| 15:49541782:C:G | A258P | 0.990 |
| 15:49575034:A:G | W208R | 0.988 |
| 15:49575034:A:T | W208R | 0.988 |
| 15:49541758:C:G | A266P | 0.986 |
| 15:49575038:A:C | F206L | 0.986 |
| 15:49575038:A:T | F206L | 0.986 |
| 15:49575040:A:G | F206L | 0.986 |
| 15:49541753:A:C | F267L | 0.985 |
| 15:49541753:A:T | F267L | 0.985 |
| 15:49541755:A:G | F267L | 0.985 |
| 15:49508316:A:G | W303R | 0.984 |
| 15:49508316:A:T | W303R | 0.984 |
| 15:49575037:A:G | W207R | 0.984 |
| 15:49575037:A:T | W207R | 0.984 |
| 15:49541717:T:A | K279N | 0.981 |
| 15:49541717:T:G | K279N | 0.981 |
| 15:49541709:A:G | L282P | 0.980 |
| 15:49335459:C:G | A437P | 0.979 |
| 15:49575014:A:C | F214L | 0.979 |
| 15:49575014:A:T | F214L | 0.979 |
| 15:49575016:A:G | F214L | 0.979 |
| 15:49611233:G:C | F29L | 0.979 |
| 15:49611233:G:T | F29L | 0.979 |
| 15:49611235:A:G | F29L | 0.979 |
| 15:49541720:A:C | F278L | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000008209 (15:49358636 C>G,T), RS1000020066 (15:49577400 T>A,C), RS1000028952 (15:49453212 T>A), RS1000036230 (15:49328215 T>A), RS1000044680 (15:49491848 G>A), RS1000060000 (15:49452837 G>A), RS1000063705 (15:49357433 A>G), RS1000069336 (15:49377372 G>A), RS1000073913 (15:49531321 T>C), RS1000083641 (15:49432021 G>A), RS1000083828 (15:49400830 C>T), RS1000087668 (15:49583613 T>C), RS1000095653 (15:49446566 T>C), RS1000099087 (15:49424129 G>A), RS1000136448 (15:49400367 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (1): autoinflammatory syndrome (MONDO:0019751)
Orphanet (1): Autoinflammatory syndrome (Orphanet:93665)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001069_2 | Thyroid volume | 3.000000e-13 |
| GCST001069_6 | Thyroid volume | 1.000000e-12 |
| GCST004744_35 | Lung adenocarcinoma | 6.000000e-10 |
| GCST004744_39 | Lung adenocarcinoma | 2.000000e-09 |
| GCST007430_57 | Peak expiratory flow | 1.000000e-09 |
| GCST007431_24 | Lung function (FEV1/FVC) | 3.000000e-27 |
| GCST007432_55 | FEV1 | 9.000000e-16 |
| GCST009391_952 | Metabolite levels | 4.000000e-06 |
| GCST010243_243 | Apolipoprotein B levels | 7.000000e-10 |
| GCST010245_36 | LDL cholesterol levels | 6.000000e-09 |
| GCST010653_86 | Thyroid stimulating hormone levels | 8.000000e-44 |
| GCST90011899_155 | Aspartate aminotransferase levels | 9.000000e-09 |
| GCST90013407_156 | Liver enzyme levels (gamma-glutamyl transferase) | 2.000000e-12 |
EFO canonical traits (8, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009718 | peak expiratory flow |
| EFO:0004713 | FEV/FVC ratio |
| EFO:0004314 | forced expiratory volume |
| EFO:0010443 | triacylglycerol 58:9 measurement |
| EFO:0004615 | apolipoprotein B measurement |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
| EFO:0004736 | aspartate aminotransferase measurement |
| EFO:0004532 | serum gamma-glutamyl transferase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Phenylmercuric Acetate | decreases expression, affects cotreatment | 2 |
| Valproic Acid | decreases methylation, decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| Esketamine | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| pentanal | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| Acetaminophen | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Malathion | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
4 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT00442182 | PHASE2 | UNKNOWN | The Efficacy and Safety of ITF2357 in AIS |
| NCT00887939 | Not specified | COMPLETED | Pathogenesis of Physical Induced Urticarial Syndromes |
| NCT03510442 | Not specified | RECRUITING | Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still’s Disease, and Related Conditions |
| NCT06248957 | Not specified | RECRUITING | SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): autoinflammatory syndrome